anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Moderna · pitchdeck

See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech

39 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech

Moderna
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 16 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 14 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides · 4 hits
— 0/2 slides
Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 19 hits
— 0/4 slides
25% 1/4 slides 75% 3/4 slides 100% 4/4 slides
— 0/4 slides
Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 14 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides · 4 hits
— 0/2 slides
Traction 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Roadmap 7 slides 100% 7/7 slides 100% 7/7 slides · 37 hits
— 0/7 slides
42.9% 3/7 slides 71.4% 5/7 slides 100% 7/7 slides
— 0/7 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
The slide features a minimalist icon representing cellular delivery and systemic impact.front_matter
Open slide detail
02
other
Open slide detail
03
show_traction
Open slide detailBeat · Traction
04
The slide uses a table to show historical growth and a text box to frame the industry's 'Risky' and 'Slow/Unscalable' nature.size_opportunity
Open slide detailBeat · Problem
05
This is a classic slide from Moderna's early pitch decks, framing mRNA as a platform technology.present_solution
Open slide detailBeat · Problem
06
The slide uses a three-part visual comparison: Native Biology, Recombinant Technology (limited), and Moderna mRNA drug (comprehensive).present_solution
Open slide detailBeat · Solution
07
Uses a software analogy to explain the platform scalability of mRNA technology.present_solution
Open slide detailBeat · Solution
08
This is a foundational slide for Moderna's platform value proposition.inspire_vision
Open slide detailBeat · Solution
09
The slide uses a process flow diagram to illustrate the integration of chemistry, process, bioinformatics, mRNA engineering, and formulation.present_solution
Open slide detailBeat · Solution
10
The slide uses a modular metaphor where triangular components build pentagonal modalities.present_solution
Open slide detail
11
The slide uses a radar chart-like pentagon icon for each modality to represent platform maturity or capability depth.present_solution
Open slide detail
12
The slide uses a radar chart (pentagon) to represent the Moderna platform across different modalities, with varying levels of shading indicating progress or invshow_traction
Open slide detail
13
Uses a custom 2D risk matrix to visualize market expansion potential.size_opportunity
Open slide detail
14
The chart uses a scatter-like timeline approach where bars represent development duration for specific vaccine candidates.plan_implementation
Open slide detailBeat · Roadmap
15
Slide 15 indicator in bottom left corner.establish_context
Open slide detailBeat · Roadmap
16
The chart is a classic S-curve representing technology adoption or maturity.present_solution
Open slide detailBeat · Roadmap
17
The slide highlights the efficiency of the R&D process, specifically mentioning 7, 10, and 12-month milestones for DC nomination.plan_implementation
Open slide detailBeat · Roadmap
18
The slide uses a linear process flow to show how external partners (Charles River, PPD) and internal capabilities (Moderna Norwood) facilitate the development epresent_solution
Open slide detailBeat · Roadmap
19
The slide highlights the company's rapid pipeline expansion since its founding in 2011.show_traction
Open slide detailBeat · Roadmap
20
The slide uses a tabular format to track clinical progress across different therapeutic areas (Viral Vaccines, Immuno-Oncology, CV).show_traction
Open slide detailBeat · Roadmap
21
The slide shows a partial view of a larger pipeline table, focusing on pandemic flu candidates.plan_implementation
Open slide detail
22
Includes a citation of a Molecular Therapy publication.show_traction
Open slide detail
23
The slide uses a standard pharmaceutical pipeline table format.plan_implementation
Open slide detail
24
Includes citation to Cell publication; shows dose-dependent efficacy.show_traction
Open slide detail
25
The slide highlights the speed of the platform by tracking specific regulatory and clinical milestones.show_traction
Open slide detail
26
The slide uses a standard pharmaceutical pipeline table format.plan_implementation
Open slide detail
27
Includes a visual representation of symptoms on a human figure and a bar chart comparing CMV disease prevalence to other childhood conditions.frame_problem
Open slide detailLoop · Cost Of Inaction
28
The slide illustrates the biological mechanism of action for Moderna's CMV vaccine candidate.present_solution
Open slide detail
29
The slide is a partial view of a larger pipeline table, focusing on the Immuno-Oncology category.plan_implementation
Open slide detail
30
The process is depicted as a cycle around a human figure, emphasizing the personalized nature of the treatment.present_solution
Open slide detail
31
The slide is a partial view of a larger pipeline table, focusing on mRNA-2905.plan_implementation
Open slide detail
32
The slide compares monotherapy (anti-PDL1, IL-12 mRNA) against combination therapy at different doses, showing a clear synergistic effect.show_traction
Open slide detail
33
The slide is a partial view of a larger pipeline table, focusing on a single row for AZD-8601.plan_implementation
Open slide detail
34
Study design timeline and bar chart showing EF% at four time points across four treatment groups.show_traction
Open slide detail
35
transition
Open slide detail
36
The table tracks cash inflows and year-end cash balances over a 5-year period.analyze_data
Open slide detail
37
The table tracks cash-based financial information; 2015 is the last audited year.show_traction
Open slide detail
38
The slide uses an S-curve (sigmoid function) to illustrate the growth trajectory of mRNA technology.argue_timing
Open slide detailLoop · Golden Circle
39
inspire_vision
Open slide detailLoop · Golden Circle